ATE267600T1 - Mikroemulsionen zur transdermalen verabreichung von apomorphin für die behandlung von morbus parkinson - Google Patents

Mikroemulsionen zur transdermalen verabreichung von apomorphin für die behandlung von morbus parkinson

Info

Publication number
ATE267600T1
ATE267600T1 AT02013398T AT02013398T ATE267600T1 AT E267600 T1 ATE267600 T1 AT E267600T1 AT 02013398 T AT02013398 T AT 02013398T AT 02013398 T AT02013398 T AT 02013398T AT E267600 T1 ATE267600 T1 AT E267600T1
Authority
AT
Austria
Prior art keywords
apomorphine
parkinson
disease
treatment
transdermal administration
Prior art date
Application number
AT02013398T
Other languages
English (en)
Inventor
Maria Rosa Gasco
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE267600T1 publication Critical patent/ATE267600T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02013398T 2001-06-22 2002-06-19 Mikroemulsionen zur transdermalen verabreichung von apomorphin für die behandlung von morbus parkinson ATE267600T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001321A ITMI20011321A1 (it) 2001-06-22 2001-06-22 Composizione farmaceutica in forma di microemulsione atta alla somministrazione per via transdermale di apomorfina utile nel trattamento del

Publications (1)

Publication Number Publication Date
ATE267600T1 true ATE267600T1 (de) 2004-06-15

Family

ID=11447920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02013398T ATE267600T1 (de) 2001-06-22 2002-06-19 Mikroemulsionen zur transdermalen verabreichung von apomorphin für die behandlung von morbus parkinson

Country Status (4)

Country Link
EP (1) EP1270007B1 (de)
AT (1) ATE267600T1 (de)
DE (1) DE60200531D1 (de)
IT (1) ITMI20011321A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004049574A1 (de) * 2004-10-12 2006-04-20 Doris Dr. Barnikol-Keuten Arzneimittel und System zur perkutanen Arzneistoffverabreichung
US20080139513A1 (en) * 2006-09-26 2008-06-12 Novavax, Inc. Transdermal deliver of active agents
US9918934B2 (en) * 2006-12-12 2018-03-20 Edgar Joel Acosta-Zara Linker-based lecithin microemulsion delivery vehicles
EP2545905A1 (de) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited Neue therapeutische Zusammensetzung mit Apomorphin als aktiver Inhaltsstoff
AU2013273138B2 (en) * 2012-06-05 2017-06-15 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
US11679124B2 (en) 2018-03-19 2023-06-20 Epicyt Pharma Ab Composition for use in the treatment of conditions caused by calcium deficiency

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
FR2732896B1 (fr) * 1995-04-11 1997-06-13 Prographarm Lab Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine

Also Published As

Publication number Publication date
EP1270007A3 (de) 2003-03-12
ITMI20011321A0 (it) 2001-06-22
EP1270007A2 (de) 2003-01-02
EP1270007B1 (de) 2004-05-26
ITMI20011321A1 (it) 2002-12-22
DE60200531D1 (de) 2004-07-01

Similar Documents

Publication Publication Date Title
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
IL221381A0 (en) 2,4-pyrimidinediamine derivatives, their use and methods for their preparation
JP2003503454A5 (de)
DOP2002000429A (es) Imidazotriazinas
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
EA200401114A2 (ru) Замещённые гидроксиэтиламины
DE602004022633D1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
SE0001899D0 (sv) New compounds
MY134129A (en) Polymorphs of an epothilone analog
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
FR2780403B3 (fr) Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
ATE367815T1 (de) Verwendung von einem vasopressin-antagonisten wie conivaptan zur herstellung eines medikaments für die behandlung der pulmonalen hypertension
CY1110401T1 (el) Παραγωγα των 1-φαινυλαλκανοκαρβοξυλικων οξεων για την αντιμετωπιση των νευροεκφυλιστικων νοσων
MXPA04005079A (es) Variantes del dominio c2 del factor viii.
DE60200531D1 (de) Mikroemulsionen zur transdermalen Verabreichung von Apomorphin für die Behandlung von Morbus Parkinson
TW200716152A (en) Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
DE60120120D1 (de) Beutelformzusammensetzungen
DE602005020178D1 (de) 5,6,7-trihydroxyheptansäure und analoge zur behandlung von augenkrankheiten und mit hyperproliferativen und angiogenen reaktionen verbundenen krankheiten
ATE345135T1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
ATE235237T1 (de) Sertralin zur behandlung von post-myocard-infarkt-patienten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties